Fund Holdings — Boxer Capital Management, LLC

Total Portfolio Value:
$332.47M
Total Bought:
$15.59M
Total Sold:
$817.56M
Net Transaction:
-$801.97M
Notable People:
Aaron Isaac Davis
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Revolution Medicines, Inc.(RVMD)4,279,4641,317,977-2,961,487$187.18M$46.60M14.02%-$140.58M
Nuvalent Inc1,120,192450,000-670,192$87.69M$31.91M9.60%-$55.77M
Merus N V1,900,000700,000-1,200,000$79.89M$29.46M8.86%-$50.43M
Avidity Biosciences Inc1,727,388865,000-862,388$50.23M$25.53M7.68%-$24.70M
Anaptysbio Inc1,300,0001,300,0000$17.21M$24.17M7.27%+$6.96M
Xenon Pharmaceuticals Inc.(XENE)600,000600,0000$23.52M$20.13M6.05%-$3.39M
Replimune Group, Inc.(REPL)1,796,3411,796,3410$21.75M$17.51M5.27%-$4.24M
Apellis Pharmaceuticals Inc
COM
1,426,000713,000-713,000$45.50M$15.59M4.69%-$29.91M
Chimerix Inc2,060,0001,810,000-250,000$7.17M$15.40M4.63%+$8.23M
Tango Therapeutics, Inc.(TNGX)10,380,99910,380,9990$32.08M$14.22M4.28%-$17.86M
Enliven Therapeutics Inc671,358671,3580$15.11M$13.21M3.97%-$1.89M
ORIC Pharmaceuticals, Inc.(ORIC)1,732,5711,732,5710$13.98M$9.67M2.91%-$4.31M
Day One Biopharmaceuticals I
COM
1,189,9431,189,9430$15.08M$9.44M2.84%-$5.64M
Kymera Therapeutics, Inc.(KYMR)425,000325,000-100,000$17.10M$8.90M2.68%-$8.20M
Prothena Corp PlcSHS
SHS
690,000690,0000$9.56M$8.54M2.57%-$1.02M
uniQure N.V.SHS(QURE)750,000750,0000$13.24M$7.95M2.39%-$5.29M
Legend Biotech CorporationADS(LEGN)700,000200,000-500,000$22.78M$6.79M2.04%-$15.99M
Nurix Therapeutics, Inc.(NRIX)563,067563,0670$10.61M$6.69M2.01%-$3.92M
Amylyx Pharmaceuticals, Inc.(AMLX)1,750,0001,750,0000$6.62M$6.20M1.86%-$420.0K
Solid Biosciences Inc01,240,700+1,240,700$0$4.59M1.38%+$4.59M
Denali Therapeutics Inc.(DNLI)0250,000+250,000$0$3.40M1.02%+$3.40M
Kodiak Sciences Inc.(KOD)1,000,0001,035,000+35,000$9.95M$2.91M0.87%-$7.04M
Prelude Therapeutics Incorporated(PRLD)1,708,1872,108,014+399,827$2.18M$1.62M0.49%-$554.8K
Instil Bio, Inc.(TIL)355,50080,125-275,375$6.79M$1.39M0.42%-$5.40M
Boundless Bio, Inc.(BOLD)250,000250,0000$725.0K$377.5K0.11%-$347.5K
Climb Bio, Inc.(CLYM)2,603,190145,000-2,458,190$4.69M$176.9K0.05%-$4.51M
Nuvation Bio Inc.W EXP 02 10 202(NUVB)266,666266,6660$61.3K$85.3K0.03%+$24.0K
Surrozen, Inc.W EXP 08 01 203(SRZN)66,66666,6660$1.7K$2.0K0.00%+$340
Apogee Therapeutics Inc86,0000-86,000$3.90M$0—-$3.90M
Arcus Biosciences, Inc.(RCUS)1,602,2000-1,602,200$23.86M$0—-$23.86M
Arvinas, Inc.(ARVN)1,058,6140-1,058,614$20.29M$0—-$20.29M
Axsome Therapeutics, Inc.(AXSM)470,0000-470,000$39.77M$0—-$39.77M
Bicara Therapeutics Inc135,0000-135,000$2.35M$0—-$2.35M
BioAtla, Inc.(BCAB)686,3470-686,347$405.8K$0—-$405.8K
Black Diamond Therapeutics I506,0000-506,000$1.08M$0—-$1.08M
Cullinan Therapeutics, Inc.(CGEM)907,8950-907,895$11.06M$0—-$11.06M
DBV Technologies S.A.ADS(DBVT)50,0000-50,000$154.5K$0—-$154.5K
Geron Corporation(GERN)6,000,0000-6,000,000$21.24M$0—-$21.24M
Immunovant, Inc.(IMVT)825,0000-825,000$20.44M$0—-$20.44M
Iovance Biotherapeutics, Inc.(IOVA)750,0000-750,000$5.55M$0—-$5.55M
iTeos Therapeutics Inc946,9150-946,915$7.27M$0—-$7.27M
Jasper Therapeutics, Inc.(JSPR)350,0000-350,000$7.48M$0—-$7.48M
Kalvista Pharmaceuticals Inc1,590,0000-1,590,000$13.47M$0—-$13.47M
Keros Therapeutics, Inc.(KROS)250,0000-250,000$3.96M$0—-$3.96M
Mersana Therapeutics Inc2,635,0000-2,635,000$3.77M$0—-$3.77M
Milestone Pharmaceuticals Inc.(MIST)309,0070-309,007$729.3K$0—-$729.3K
Olema Pharmaceuticals, Inc.(OLMA)650,0000-650,000$3.79M$0—-$3.79M
Orchestra BioMed Holdings, Inc.(OBIO)238,1930-238,193$952.8K$0—-$952.8K
Poseida Therapeutics Inc2,000,0000-2,000,000$19.20M$0—-$19.20M
Relay Therapeutics, Inc.(RLAY)536,1320-536,132$2.21M$0—-$2.21M
Rocket Pharmaceuticals, Inc.(RCKT)1,466,0510-1,466,051$18.43M$0—-$18.43M
Sana Biotechnology, Inc.(SANA)1,545,0000-1,545,000$2.52M$0—-$2.52M
Scholar Rock Holding Corporation(SRRK)750,0000-750,000$32.41M$0—-$32.41M
Springworks Therapeutics Inc3,421,5410-3,421,541$123.62M$0—-$123.62M
Spyre Therapeutics, Inc.(SYRE)466,6800-466,680$10.86M$0—-$10.86M
Structure Therapeutics IncADS500,0000-500,000$13.56M$0—-$13.56M
Summit Therapeutics Inc.(SMMT)250,0000-250,000$4.46M$0—-$4.46M
Terns Pharmaceuticals Inc752,0000-752,000$4.17M$0—-$4.17M
Third Harmonic Bio Inc2,000,0000-2,000,000$20.58M$0—-$20.58M
Tyra Biosciences, Inc.(TYRA)2,027,6780-2,027,678$28.18M$0—-$28.18M
Zentalis Pharmaceuticals, Inc.(ZNTL)450,0000-450,000$1.36M$0—-$1.36M
Zura Bio LimitedCL A(ZURA)300,0000-300,000$750.0K$0—-$750.0K
Page 1 of 1
Boxer Capital Management, LLC — 13F Holdings — Q1 2025 | TickerTrail